Target Audience
- Healthcare professionals and researchers involved in MS clinical care or research.
- Neurologists
- Clinical Researchers
- Residents with interest in Neurology
Congress Highlights
- MS Diagnosis
- Biomarkers in MS
- MS Treatment
- Update on Progressive MS
- Oral Presentations
- Updates in MS
- The Role of Patient Reported Outcomes
- NMOSD and MOGAD
- Hot Topics in MS
Why Attend the Tenth MENACTRIMS Congress?
- Learn about the latest advancements in Multiple Sclerosis (MS) research, including innovative therapies and new treatment approaches.
- Discover the role of biomarkers and precision medicine in personalizing MS treatment strategies.
- Understand the impact of genetics and environmental factors in MS pathogenesis and risk assessment.
- Explore cutting-edge disease-modifying therapies (DMTs) and their role in slowing disease progression.
- Gain insights into advanced imaging techniques, including high-resolution MRI, for better MS diagnosis and monitoring.
- Learn about the latest guidelines and updates in MS management, including best practices for relapse treatment and symptom control.
- Explore advancements in neurorehabilitation, lifestyle interventions, and mental health management for MS patients.
- Stay updated on novel treatment targets and immunotherapy advancements in MS.
- Discuss challenges in MS patient care, disability management, and healthcare policies to enhance quality of life.
Congress Overview
- Pre-congress on December 4, 2025
- Plenary sessions covering all major topics in MS
- Full day parallel session in
collaboration with the IOMSNCMSC aimed at MENA region nurses - European Charcot Foundation Symposium
Pre-congress Overview
Pre-congress activities include MENACTRIMS Pre-Congress activities, Neuroimaging and Neuroradiology parallel courses, along with Educational Foundation and industry-driven pre-congress sessions taking place in Baraha 1 and 2.
Pre-congress registrations have a separate form — please click the buttons below to visit the respective pre-congress pages.
Accreditation
MENACTRIMS is granted 12.0 CME (Category 1) by Dubai Health
Congress Organizer
Phone: +971 50 9299239
Email: communications@lumina.ae
Web: www.lumina.ae